+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammatory Bowel Disease Drug"

From
Global Inflammatory Bowel Disease Market 2023-2027 - Product Thumbnail Image

Global Inflammatory Bowel Disease Market 2023-2027

  • Report
  • June 2023
  • 165 Pages
  • Global
From
Crohn's Disease (CD) Treatment Global Market Report 2024 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Autoimmune Disorder Therapies: Global Markets - Product Thumbnail Image

Autoimmune Disorder Therapies: Global Markets

  • Report
  • October 2020
  • 156 Pages
  • Global
From
From
From
Global Ulcerative Colitis (UC) - Pipeline Insight, 2022 - Product Thumbnail Image

Global Ulcerative Colitis (UC) - Pipeline Insight, 2022

  • Clinical Trials
  • August 2022
  • 210 Pages
  • Global
From
From
From
From
From
Global Autoimmune Drugs Market 2023-2027 - Product Thumbnail Image

Global Autoimmune Drugs Market 2023-2027

  • Report
  • January 2023
  • 173 Pages
  • Global
From
Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • August 2020
  • 1756 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market includes drugs used to treat Inflammatory Bowel Disease (IBD). IBD is a chronic condition that causes inflammation of the digestive tract, leading to abdominal pain, diarrhea, and other symptoms. IBD drugs are used to reduce inflammation and improve symptoms. These drugs include corticosteroids, immunomodulators, biologics, and other medications. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunomodulators are used to modify the immune system's response to inflammation. Biologics are used to target specific molecules involved in the inflammatory process. Some companies in the IBD drug market include AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Janssen, Merck, Pfizer, and Takeda. Show Less Read more